Why the study?
Rotavirus is the leading cause of severe acute gastroenteritis in children under 5 worldwide, with sub-Saharan Africa bearing a major burden of diarrheal deaths.
Does rotavirus vaccine introduction change the prevalence and genotype diversity of rotavirus infection in children under 5 with acute gastroenteritis in South Africa?
Does rotavirus vaccine introduction change the prevalence and genotype diversity of rotavirus infection in children under 5 with acute gastroenteritis in South Africa?
Answers are grounded in this paper and cite their sources.
Rotavirus vaccine introduction in South Africa was associated with a slight reduction in overall rotavirus prevalence but a significant shift in genotype diversity, highlighting the need for ongoing surveillance.
Rotavirus is the most significant cause of severe acute gastroenteritis among children under 5 years of age, worldwide. Sub-Saharan Africa particularly bears the brunt of the diarrheal deaths. A meta-analysis was conducted on 43 eligible studies published between 1982 and 2020 to estimate the pooled prevalence of rotavirus infection and changes in the main rotavirus strains circulating before and after vaccine introduction among under-five children in South Africa. The pooled national prevalence of rotavirus infection was estimated at 24% (95% CI: 21-27%) for the pre-vaccination period and decreased to 23% (95% CI: 21-25%) in the post-vaccination period. However, an increased number of cases was observed in the KwaZulu-Natal (21-28%) and Western Cape (18-24%) regions post-vaccination. The most dominant genotype combinations in the pre-vaccine era was G1P[8], followed by G2P[4], G3P[8], and G1P[6]. After vaccine introduction, a greater genotype diversity was observed, with G9P[8] emerging as the predominant genotype combination, followed by G2P[4], G12P[8], and G1P[8]. The introduction of the rotavirus vaccine was associated with a reduction in the burden of rotavirus-associated diarrhea in South Africa, although not without regional fluctuation. The observed changing patterns of genotype distribution highlights the need for ongoing surveillance to monitor the disease trend and to identify any potential effects associated with the dynamics of genotype changes on vaccine pressure/failure.
No takes yet. Share an insight, caveat, or question.
Omatola et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: